Suppr超能文献

基于药效团的虚拟筛选、含脲/硫脲部分的新型吡咯里嗪的合成、生物评价和分子对接研究,具有潜在的细胞毒性和 CDK 抑制活性。

Pharmacophore-based virtual screening, synthesis, biological evaluation, and molecular docking study of novel pyrrolizines bearing urea/thiourea moieties with potential cytotoxicity and CDK inhibitory activities.

机构信息

Science and Technology Unit (STU), Umm Al-Qura University, Makkah, Saudi Arabia.

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia.

出版信息

J Enzyme Inhib Med Chem. 2021 Dec;36(1):15-33. doi: 10.1080/14756366.2020.1837124.

Abstract

In the current study, virtual screening of a small library of 1302 pyrrolizines bearing urea/thiourea moieties was performed. The top-scoring hits were synthesised and evaluated for their cytotoxicity against three cancer (MCF-7, A2780, and HT29) and one normal (MRC-5) cell lines. The results of the MTT assay revealed potent cytotoxic activities for most of the new compounds (IC = 0.16-34.13 μM). The drug-likeness study revealed that all the new compounds conform to Lipinski's rule. Mechanistic studies of compounds , , and revealed the induction of apoptosis and cell cycle arrest at the G phase in MCF-7 cells. The three compounds also displayed potent inhibitory activity against CDK-2 (IC = 25.53-115.30 nM). Moreover, the docking study revealed a nice fitting of compound into the active sites of CDK-2/6/9. These preliminary results suggested that compound could serve as a promising scaffold in the discovery of new potent anticancer agents.

摘要

在本研究中,对包含脲/硫脲部分的 1302 个吡咯里嗪的小文库进行了虚拟筛选。对得分最高的化合物进行了合成,并评估了它们对三种癌细胞(MCF-7、A2780 和 HT29)和一种正常细胞系(MRC-5)的细胞毒性。MTT 测定的结果表明,大多数新化合物具有很强的细胞毒性(IC = 0.16-34.13 μM)。药物相似性研究表明,所有新化合物均符合 Lipinski 规则。化合物 、 和 的机制研究表明,它们在 MCF-7 细胞中诱导细胞凋亡和 G 期细胞周期停滞。这三种化合物对 CDK-2 也表现出很强的抑制活性(IC = 25.53-115.30 nM)。此外,对接研究表明化合物 与 CDK-2/6/9 的活性位点拟合良好。这些初步结果表明,化合物 可能成为发现新型有效抗癌药物的有前途的支架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/e23a/7594867/f3e84e3f678a/IENZ_A_1837124_UF0001_C.jpg

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验